PharmaShots | Incisive News in 3 Shots

Subscribe Now

Syndax Pharmaceuticals

Syndax Publishes the Pivotal AUGMENT-101 Study Data of Revumenib for R/R KMT2Ar Acute Leukemia in the Journal of Clinical Oncology

Syndax Publishes the Pivotal AUGMENT-101 Study Data of Revumenib for R/R KMT2Ar Acute Leukemia in the Journal of Clinical Oncology

August 13, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us